Literature DB >> 16137881

4-Phenylcoumarins as HIV transcription inhibitors.

Luis M Bedoya1, Manuela Beltrán, Rocío Sancho, Dionisio A Olmedo, Sonsoles Sánchez-Palomino, Esther del Olmo, José L López-Pérez, Eduardo Muñoz, Arturo San Feliciano, José Alcamí.   

Abstract

We have evaluated the anti-HIV activity of eleven natural 4-phenylcoumarins isolated from Marila pluricostata and three of their derivatives. Antiviral activity was assessed on MT-2 cells infected with viral clones carrying the luciferase gene as reporter. Inhibitions of HIV transcription and Tat function were tested on cells stably transfected with the HIV-LTR and Tat protein. Most of the coumarins tested displayed NF-kappaB inhibition. Two coumarins were also Tat antagonists and the presence of both activities correlated with a stronger inhibition of HIV replication. Our results show that antiviral effect of 4-phenylcoumarins can be related to the inhibition of NF-kappaB and Tat, and suggest that these types of compounds can be useful in the treatment of HIV infection as viral transcription inhibitors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16137881     DOI: 10.1016/j.bmcl.2005.07.041

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  14 in total

1.  Mammea E/BB, an isoprenylated dihydroxycoumarin protonophore that potently uncouples mitochondrial electron transport, disrupts hypoxic signaling in tumor cells.

Authors:  Lin Du; Fakhri Mahdi; Mika B Jekabsons; Dale G Nagle; Yu-Dong Zhou
Journal:  J Nat Prod       Date:  2010-10-07       Impact factor: 4.050

2.  6-Butyryl-5-hy-droxy-4-phenyl-seselin.

Authors:  Thammarat Aree; Santi Tip-Pyang; Preecha Sowanthip
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-08-28

3.  Natural coumarins as potential anti-SARS-CoV-2 agents supported by docking analysis.

Authors:  Usama Ramadan Abdelmohsen; Amgad Albohy; Basma S Abdulrazik; Soad A L Bayoumi; Lourin G Malak; Iman S A Khallaf; Gerhard Bringmann; Salwa F Farag
Journal:  RSC Adv       Date:  2021-05-07       Impact factor: 4.036

4.  BF3·Et2O Catalysed 4-Aryl-3-phenyl-benzopyrones, Pro-SERMs, and Their Characterization.

Authors:  Ambika Srivastava; Pooja Singh; Rajesh Kumar
Journal:  Adv Pharmacol Sci       Date:  2015-09-01

5.  Extraction, characterization and biological studies of phytochemicals from Mammea suriga.

Authors:  Mahesha M Poojary; Kanivebagilu A Vishnumurthy; Airody Vasudeva Adhikari
Journal:  J Pharm Anal       Date:  2015-01-19

6.  The Continuing Evolution of HIV-1 Therapy: Identification and Development of Novel Antiretroviral Agents Targeting Viral and Cellular Targets.

Authors:  Tracy L Hartman; Robert W Buckheit
Journal:  Mol Biol Int       Date:  2012-07-10

7.  Strategies to Block HIV Transcription: Focus on Small Molecule Tat Inhibitors.

Authors:  Guillaume Mousseau; Susana Valente
Journal:  Biology (Basel)       Date:  2012-11-19

Review 8.  Medicinal Plants Used in the Treatment of Human Immunodeficiency Virus.

Authors:  Bahare Salehi; Nanjangud V Anil Kumar; Bilge Şener; Mehdi Sharifi-Rad; Mehtap Kılıç; Gail B Mahady; Sanja Vlaisavljevic; Marcello Iriti; Farzad Kobarfard; William N Setzer; Seyed Abdulmajid Ayatollahi; Athar Ata; Javad Sharifi-Rad
Journal:  Int J Mol Sci       Date:  2018-05-14       Impact factor: 5.923

9.  3-Phenylcoumarins as inhibitors of HIV-1 replication.

Authors:  Dionisio Olmedo; Rocío Sancho; Luis M Bedoya; José L López-Pérez; Esther Del Olmo; Eduardo Muñoz; José Alcamí; Mahabir P Gupta; Arturo San Feliciano
Journal:  Molecules       Date:  2012-08-02       Impact factor: 4.411

10.  A new cytotoxic friedelane acid--pluricostatic acid--and other compounds from the leaves of Marila pluricostata.

Authors:  Dionisio A Olmedo; José L López-Pérez; Esther del Olmo; Yelkaira Vásquez; Arturo San Feliciano; Mahabir P Gupta
Journal:  Molecules       Date:  2008-11-25       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.